This photograph shows an outside view with the logo of British pharmaceutical company GSK on a building facade during the opening of a new centre dedicated to accelerating vaccine development in Rixensart, on June 9, 2026. The British pharmaceutical giant GSK opens a new research centre in Belgium and also announced on June 9, 2026, that it had reached an agreement to acquire the US biopharmaceutical company Nuvalent, which specialises in the development of cancer therapies, "for $10.6 billion" (9.18 billion). (Photo by ERIC LALMAND / Belga / AFP via Getty Images) / Belgium OUT